Clinical Trials Browser

Phase 2 × Cetuximab × Sarcoma × Clear all

NCT05041127 2026-02-19

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Phase 2 Active not recruiting

Chordoma

NCT01063075 2019-09-26

A Study in Advanced Solid Tumors

Phase 2 Completed

34 enrolled 15 charts

Head & NeckSarcoma

Carcinoma, Head and Neck Neoplasms, Sarcoma